# Dose-finding Study for AdimrSC-2f Vaccine

> **NCT05104489** · PHASE1,PHASE2 · COMPLETED · sponsor: **Adimmune Corporation** · enrollment: 241 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** AdimrSC-2f

## Key facts

- **NCT ID:** NCT05104489
- **Lead sponsor:** Adimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-03
- **Primary completion:** 2022-12-29
- **Final completion:** 2023-07-26
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05104489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05104489, "Dose-finding Study for AdimrSC-2f Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05104489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*